Artificial intelligence (AI) has the potential to streamline medical product R&D processes in a multitude of ways, from assisting in robotic surgery to rapidly analyzing large swathes of clinical trial data.
However, with great potential comes great risk, at least in the eyes of the European Commission, which in April 2021...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?